MIMETICA PTY LTD has a total of 42 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are WYETH HOLDINGS CORP MADISON, BERGNES GUSTAVE and SYNTEX LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Australia | 3 | |
#5 | Brazil | 3 | |
#6 | Canada | 3 | |
#7 | China | 3 | |
#8 | Israel | 3 | |
#9 | Republic of Korea | 3 | |
#10 | Mexico | 3 | |
#11 | New Zealand | 3 | |
#12 | Hong Kong | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Specific use of cosmetics | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Cassidy Peter Joseph | 33 |
#2 | Blaskovich Mark Arnold Thomas | 31 |
#3 | Mark Arnold Thomas Blaskovich | 5 |
#4 | Peter Joseph Cassidy | 5 |
#5 | Alewood Paul Francis | 3 |
#6 | Hunt Peter Alan | 2 |
#7 | Ramsdale Tracie Elizabeh | 1 |
#8 | Ramsdale Tracie Elizabeth | 1 |
#9 | Cassidy Peter J | 1 |
#10 | Vernall Andrea Joy | 1 |
Publication | Filing date | Title |
---|---|---|
US2011263572A1 | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5-receptor antagonists | |
US2009275727A1 | Peptide turn mimetics | |
WO2010096854A1 | Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors | |
MX2010009488A | Methods of modulating the activity of the mc5 receptor and treatment of conditions related to this receptor. | |
WO2010096853A1 | Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor | |
CA2716256A1 | 3-substituted-1,4-diazepan-2-one melanocortin-5 receptor antagonists | |
US2009221557A1 | 3-aminoalkyl-1,4-diazepan-2-one melanocortin-5 receptor antagonists | |
US2009221558A1 | Methods of modulating the activity of the MC5 receptor and treatment of conditions related to this receptor |